GENE ONLINE|News &
Opinion
Blog

2022-12-26| Special

GeneOnline’s Pick: Top 10 Industry News Stories in 2022

by Richard Chau
Share To
2022 is a year full of changes and uncertainties in the international arena. In February, Russia launched an invasion of Ukraine, and the war has been raging on since then. Besides, as the global pandemic is gradually easing, countries are gradually progressing towards a return to normal. Apart from the Russo-Ukrainian war and the COVID-19 pandemic, there are a number of significant events that have shaken the global biotech and pharmaceutical industry throughout this year. As 2022 draws to a close, explore GeneOnline's round-up of industry news stories that dominated the year.

1. How Did the Russian Invasion of Ukraine Affect Global Biopharma?


It's free! Log in now to read

LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top